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Virus-derived DNA drives mosquito vector
tolerance to arboviral infection
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Nidia Schemmel-Jofre1, Gael Cristofari3,4, Louis Lambrechts5, Marco Vignuzzi2 & Maria-Carla Saleh1
Mosquitoes develop long-lasting viral infections without substantial deleterious effects,
despite high viral loads. This makes mosquitoes efﬁcient vectors for emerging viral diseases
with enormous burden on public health. How mosquitoes resist and/or tolerate these viruses
is poorly understood. Here we show that two species of Aedes mosquitoes infected with two
arboviruses from distinct families (dengue or chikungunya) generate a viral-derived
DNA (vDNA) that is essential for mosquito survival and viral tolerance. Inhibition of vDNA
formation leads to extreme susceptibility to viral infections, reduction of viral small RNAs due
to an impaired immune response, and loss of viral tolerance. Our results highlight an essential
role of vDNA in viral tolerance that allows mosquito survival and thus may be important
for arbovirus dissemination and transmission. Elucidating the mechanisms of mosquito
tolerance to arbovirus infection paves the way to conceptualize new antivectorial strategies to
selectively eliminate arbovirus-infected mosquitoes.
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A
rthropods play an essential role in global ecosystems and
in the development of agricultural economies. However,
some of them are capable of spreading severe pathogens
to humans, livestock and crops resulting in devastating
consequences. Among these, mosquitoes cause hundreds of
millions of infections every year1, as they are vectors for a wide
variety of pathogens including malaria parasites and arboviruses
(arthropod-borne viruses) such as dengue, Zika and chikungunya
(CHIKV) viruses. Despite their impact, little is known about
the mechanisms by which mosquitoes are able to carry and
transmit viral pathogens.
Currently, the majority of our knowledge on insect antiviral
immune responses comes from studies in Drosophila melanogaster2
and more limited work in mosquitoes3–8. These reports have
revealed the essential role of RNA interference (RNAi) pathways in
antiviral immune responses, which include the small interfering
RNA (siRNA) pathway in both Drosophila and mosquitoes, as
well as the contribution of the piwi-interacting RNA (piRNA)
pathway solely in mosquitoes6,9–12. To elicit an antiviral response,
the siRNA pathway is triggered by double-stranded RNA (dsRNA)
molecules from viral genomes and replicative intermediates.
These pathogen-associated molecular patterns are recognized and
cleaved by Dicer-2 (Dcr-2) into 21nts viral siRNAs (vsiRNA).
Once produced, vsiRNAs guide the sequence-speciﬁc recognition
and cleavage of viral RNAs by Argonaute-2 (ref. 13). On the
other hand, piRNAs range in size between 26 and 31nts with a
bias for a 50 uridine in both vertebrates and invertebrates14,15.
Although they have been mostly linked to epigenetic and
post-transcriptional silencing of retrotransposons and other
genetic elements in the germ line, some studies have also
suggested an antiviral role in mosquito somatic cells6,8,9,12,16.
While these antiviral pathways help to control infections in
insects, they do not eliminate viral pathogens, resulting in a
long-lasting viral infection or the so-called viral persistent
infection with minor ﬁtness costs for the host. Such a situation
of low virulence and the ability to buffer the negative impacts on
host ﬁtness, despite high pathogen load, has been described as a
defense strategy called tolerance17,18. Tolerance diverts fewer
resources from the immune response and minimizes the resulting
self-inﬂicted damages. Thus, immune tolerance is an adaptive
strategy in terms of survival to a recurrent pathogen and its
associated damage19. In contrast, a strategy called resistance,
involves the activation of immune pathways that target pathogens
to control their replication. Resistance avoids infection, reduces
pathogen load and eventually results in pathogen clearance20,21.
Nevertheless, successful clearance through resistance is often
costly in terms of energy and resources20,22. Both tolerance and
resistance rely on sensing mechanisms and on a threshold of
responsiveness. A prevailing model postulates that danger signals
are required to activate an appropriate defense against pathogens,
which could be released by damaged infected tissues, and that
the levels of these signals should correlate with a damage
threshold19,23–25.
Recently, we showed that ﬂies infected with RNA viruses
produce viral-derived DNA (vDNA) molecules through the
activity of endogenous retrotransposons, a cellular source of
reverse transcriptase activity. These vDNA molecules boost the
RNAi-mediated antiviral immune response and are indispensable
for establishing persistent viral infections in Drosophila
melanogaster26. Since arboviruses are nearly all RNA viruses,
while belonging to a wide range of viral families, we hypothesized
that vDNA synthesis could also impact arboviral dissemination
and transmission, and thus could be a general phenomenon
involved in viral defense in arthropods. Notably, it could provide
a molecular basis to explain how mosquitoes maintain persistent
infections to become efﬁcient vectors of viral pathogens.
Here we show that arbovirus-infected mosquitoes produce
vDNA forms, which are essential for the insect’s survival. When
vDNA production is inhibited, the levels of virus-speciﬁc small
RNA are reduced and mosquitoes die from a loss of tolerance
towards viral infection. We speculate that these vDNA molecules
might act as a danger signal to reach and maintain a state of
tolerance response, leading to persistent infection in the host.
Results
Mosquito cells produce arbovirus-derived DNA in vitro. We
previously identiﬁed a link between vDNA molecules and viral
persistence in the insect model Drosophila melanogaster26.
However, the presence of similar mechanisms in other
arthropods, including vectors of human disease such as
mosquitoes, is unknown. To explore this possibility, we used
the arbovirus CHIKV from the Indian Ocean lineage, and its
mosquito vectors Aedes albopictus and Aedes aegypti. To assess
the presence of CHIKV-speciﬁc vDNA, we ﬁrst optimized PCR
and primer conditions to minimize and remove nonspeciﬁc
ampliﬁcation (data not shown). Using multiple primer
pairs spanning the entire CHIKV genome, we identiﬁed two
primer pairs that generated amplicons of roughly 600 and 200 bp
in the nonstructural proteins (nSP) 2 and 4, respectively, that
had no cross-reactivity with uninfected cells (Fig. 1a). As
this PCR approach speciﬁcally ampliﬁes two regions of the
virus as vDNA, we cannot exclude that other vDNA segments
might also be synthesized, but not detected by our assay. In
D. melanogaster, vDNA is highly rearranged compared with its
vRNA counterpart26. This phenomenon might explain why by
conventional PCR we did not detect more vDNA species. We
then infected Ae. albopictus and Ae. aegypti cell lines with CHIKV
and looked for the presence of vDNA by virus-speciﬁc PCR. We
detected vDNA in all cell lines tested (Fig. 1b) and a kinetic
analysis of vDNA synthesis revealed that it can be detected as
early as 6 h after infection in Ae. albopictus cell lines (C6/36 and
U4.4 cells) and 12 h after infection in Ae. aegypti cells (Aag2)
(Fig. 1b, full gels available in Supplementary Fig. 9).
Cellular reverse transcriptase activity originating from
endogenous retrotransposons is responsible for vDNA formation
in Drosophila26. To test if this could also be the case in
mosquito species, and to get insight into the mechanism
of vDNA formation, we ﬁrst treated mosquito cell lines with
azidothymidine (AZT), a reverse transcriptase inhibitor
previously shown to inhibit the synthesis of vDNA in
Drosophila26. Indeed, addition of AZT to the culture medium
at the time of infection prevents CHIKV vDNA accumulation in a
dose-dependent manner, with complete inhibition reached at
5mM AZT (Fig. 1c, full gels available in Supplementary Fig. 9).
Importantly, AZT treatment does not reduce viral titres nor viral
RNA synthesis, suggesting that this drug does not interfere
with viral RNA replication (Supplementary Fig. 1a,b). Finally,
given the function of AZT as a reverse transcriptase inhibitor,
we hypothesized that cellular reverse transcriptase activity is
playing a major mechanistic role in vDNA synthesis. Indeed, we
could detect endogenous reverse transcriptase activity in
non-infected mosquito cell extracts (Supplementary Fig. 1c);
and this activity is sensitive to AZT-triphosphate (AZTTP)
in vitro (Fig. 1d,e). Taken together, these data show that Ae.
albopictus and Ae. aegypti cells can generate CHIKV-speciﬁc
vDNA and that its synthesis is dependent on a cellular reverse
transcriptase activity.
To determine whether vDNA has an effect on the cellular
immune response, we generated small RNA libraries from Ae.
albopictus cells 3 days after CHIKV infection. As previously
described27, C6/36 cells mainly produce viral-speciﬁc piRNAs
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(vpiRNAs; 27–29 nts, Supplementary Fig. 2a–f) with a ping-pong
signature, indicative of an ampliﬁcation process, and a U1 bias for
anti-sense small RNAs and an enrichment of A10 in sense small
RNAs (Supplementary Fig. 2g,h). AZT treatment of this cell line
did not result in changes in vsiRNAs or vpiRNAs (Supplementary
Fig. 2i,j). In U4.4 cells, we observed the generation of both
vpiRNAs and viral-speciﬁc siRNAs (vsiRNAs), during CHIKV
infection (Fig. 2a,b)6. In addition, we found that vpiRNAs are
mainly generated from the subgenomic region of the CHIKV
genome, whereas vsiRNAs align over the entire CHIKV genome
(Fig. 2c–f). Interestingly, when U4.4 cells were treated with AZT
to inhibit vDNA synthesis, we did not observe major changes in
the levels of endogenous or vsiRNAs (Fig. 2i). However, we
observed a decrease in the amount of endogenous piRNAs and
vpiRNAs with no change of the endogenous microRNAs
(miRNA), indicating that AZT treatment is interfering with
piRNA production in cultured cells (Fig. 2j). Although AZT does
not interfere with vsiRNA production in U4.4 cells, it could still
interfere with the siRNA pathway, downstream of vsiRNAs
production, for example, by reducing its silencing activity. To test
this possibility, we employed an in vitro luciferase-silencing assay
in the absence or presence of AZT. We found that AZT treatment
of mosquito cells had no effect on silencing, indicating that the
RNAi pathway remains functional (Supplementary Fig. 3).
These results suggest that, in cultured mosquito cells,
reverse-transcriptase-mediated vDNA formation can inﬂuence
viral small RNA production, particularly vpiRNAs, but does not
seem to impact vsiRNA production or function.
vDNA is required for viral small RNA production in vivo.
Given the presence of CHIKV vDNA in infected mosquito
cells in vitro, we next addressed whether vDNA can also form
in vivo. We infected Ae. albopictus mosquitoes with CHIKV,
allowed the infection to develop for 9 days (during the peak of
viral replication), and then looked for the presence of vDNA.
C6
/3
6
U4
.4
n.i. CHIKV 0.1 MOI
hpi
a
C6
/3
6
U4
.4
PC
R
R
T-
PC
R
b c n.i. CHIKV 0.1 MOI
C6
/3
6
U4
.4
C6
/3
6
U4
.4
PC
R
R
T-
PC
R
Aa
g2
Aa
g2
Aa
g2
Aa
g2
48241261 0 0 1 2.5 5 mM AZT
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
CHIKV
18S
S2
U4.4
C6/36
Aag2
H
ea
t
10.10.010
[AZT-3P], mMd e
50
100
0 mM AZT
 
0.01 mM AZT
 
0.1 mM AZT
 
1 mM AZT
 
Heat
S2 C6/36 U4.4 Aag2
%
 R
T 
ac
tiv
ity
 
 
**
***
***
***
****
****
****
****
****
***
***
***
***
***
***
***
nsP1 nsP2 nsP3 nsP4 Capsid E35′Cap E2 E1 3′UTR 3′PolyA5′UTR
6K
Figure 1 | Mosquito cells produce host reverse transcriptase-dependent arbovirus-derived DNA. (a) Schematic of CHIKV viral genome. Top arrows
indicate the position of the genomic and subgenomic promoters. Bottom arrows indicate the position of the primers used for vDNA detection. (b) Kinetics
of vDNA synthesis. C6/36, U4.4 and Aag2 cells were infected with CHIKV at a MOI of 0.1 and cells were harvested at the indicated time points. Cells were
analysed by PCR (upper panel) for vDNA detection. RT-PCR (lower panel) was used to follow viral infections. Non-infected cells (n.i) were used as a
negative control and cellular 18S rRNA was used as a housekeeping gene loading control. (c) AZT inhibits vDNA synthesis in vitro. C6/36, U4.4 and Aag2
cells were treated with increasing concentration of AZT for 2 days. At the indicated time point, cells were harvested and vDNA and RNA were assessed as
described in b. (d–e) Endogenous reverse transcriptase activity in insect cells. (d) Dose-dependent AZT inhibition was tested in insect cell extracts and
(e) quantiﬁcation of reverse transcriptase inhibition expressed as an activity percentage of non-treated extracts. Heat inactivated samples (heat) were used
as negative controls. Drosophila S2 cells were used as a positive control. Each experiment was completed at least 3 times. Error bars correspond to the s.d. t-
test with Welch’s correction was used to determine statistical signiﬁcance compared with the untreated control as a reference (**Po0.01; ***Po0.001;
****Po0.0001).
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CHIKV vDNA was detected in all infected mosquitoes, whereas
non-infected individuals were negative for both CHIKV vDNA
and RNA (Fig. 3a, full gels available in Supplementary Fig. 10),
indicating that vDNA is not only generated in cultured cells but
also in vivo. We also searched for vDNA generated on infection of
Ae. aegypti with dengue virus and, as for CHIKV, we readily
detected vDNA (Supplementary Fig. 4), suggesting that the
presence of vDNA is a common feature of arboviral infections
found in mosquitoes from different species (Ae. albopictus and
Ae. aegypti, respectively) harbouring arboviruses from different
families (Togaviridae and Flaviviridae for CHIKV and dengue
virus, respectively).
To address whether vDNA contributes to the RNAi response
in vivo, we looked at the small RNA proﬁles of mosquitoes at 3
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Figure 2 | Chikungunya vDNA is required for small viral RNA production in cultured cells. vDNA contributes to the production of vpiRNAs in mosquito
cell lines. Infected U4.4 cells were (a) left untreated (clear bars) or (b) treated with 5mM AZT (green bars) for 3 days. Graph represents the size
distribution of the total number of CHIKV-speciﬁc small RNA reads (ranging from 18 to 33 nts) normalized to the total number of reads. (c) vsiRNAs in
U4.4 cells show homogenous coverage over the entire genome. (d) vsiRNA coverage in AZT-treated cells. Uncovered regions are represented as grey lines.
The coverage of vpiRNAs on the CHIKV genome in (e) untreated cells or (f) AZT-treated cells. Most of the CHIKV vpiRNA reads belong to the 30-terminal
region on the viral genome. The sense and anti-sense small RNAs are in red and green, respectively. (g-h) Relative nucleotide frequency per position of the
27–29nt viral small RNAs that map to the sense and anti-sense strand of the viral genome, red and green respectively. The intensity varied in correlation
with the frequency. A nucleotide bias (U1 and A10) is observed. (i,j) Accumulation of viral and cellular small RNAs in U4.4 cells 3 days post CHIKV
infection in the presence (AZT pos) or absence (AZT neg) of AZT, assessed as (i) mapping of small RNAs corresponding to CHIKV vsiRNA (green),
endo-siRNA (purple) belonging to the gene GAPW01000199 or to miRNA (blue). For miRNA each dot represents one miRNA. For siRNAs each dot
represents the coverage of a region of 20 bases of the target RNA. The lines for miRNA and endo-siRNA are superposed. (j) Mapping of small RNA
corresponding to CHIKV vpiRNA (orange), endo-piRNA (red) belonging to the gene GAPW01000199 or to miRNA (blue). For miRNAs each dot represents
one miRNA. For piRNAs each dot represents the coverage of a region of 20 bases of the target RNA. For (i,j) lines represent the linear trendline of each set
of values. The equation and R2 value of each regression are also mentioned.
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days (early, Fig. 3b–k) and 9 days (late, Supplementary Fig. 5)
post-infection, with or without AZT treatment. To do this, we
allowed female mosquitoes to feed for 2 days on sucrose alone or
sucrose supplemented with 5 or 10mgml 1 of AZT to suppress
endogenous reverse transcriptase activity before infection.
Mosquitoes were then infected with CHIKV via artiﬁcial blood
meal and AZT was supplied daily throughout the duration of the
experiment. Interestingly, and in contrast to what we observed in
cultured cells, in the absence of AZT (and thus in the presence of
vDNA), the majority of virus-speciﬁc small RNAs were vsiRNAs
(Fig. 3b) and the small fraction of detected vpiRNA-like
molecules lacked a ping-pong signature (Fig. 3h). Both types of
small RNAs span the entire CHIKV genome sequence (Fig. 3d-g).
On AZT treatment, we observed a decrease of vsiRNA and
vpiRNA-like levels in mosquitoes at day 3 post-infection,
consistent with a role for vDNA in the production of vsiRNAs
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and possibly vpiRNA precursors in vivo (Fig. 3j,k). These changes
of viral small RNA levels were not accompanied by alterations of
the size distribution of these RNAs (Fig. 3c), nor by a change in
the global levels of endogenous miRNAs or siRNAs (Fig. 3j-k),
indicating that AZT does not interfere in general with the RNAi
machinery in vivo. When we analysed viral small RNAs at a later
stage of the infection (9 days post-infection), we detected
increased levels of vsiRNA in both AZT-treated and -untreated
mosquitoes, as compared with earlier stage, as well as the
production of vpiRNAs presenting now a ping-pong signature
(canonical vpiRNAs; Supplementary Fig. 5). As observed in
cultured cells, vsiRNA reads cover the entire CHIKV genome
where vpiRNA reads align to the subgenomic region. When
we analysed the viral small RNA response at day 3 post-infection
in mosquitoes treated with 10mgml 1 AZT, we found an
even stronger reduction of vsiRNAs (Supplementary Fig. 6),
conﬁrming the role of vDNA in the early phase of viral small
RNAs production. These results indicate that, in vivo, mosquitoes
use a siRNA-speciﬁc response to control and maintain CHIKV
infection and that early vsiRNA population is dependent on
vDNA synthesis.
vDNA is essential for mosquito tolerance to arbovirus infection.
To address whether vDNA is related to viral maintenance by
resistance or tolerance, we compared mosquito survival and viral
titres between AZT-treated insects and their untreated controls on
viral challenge. As expected, non-infected mosquitoes (whether
untreated or AZT-treated) and infected (yet untreated) mosquitoes
survived the 14 days duration period of the experiment (Fig. 4a).
However, CHIKV-infected mosquitoes that were treated with 5
or 10mgml 1 of AZT died rapidly over the course of 2 weeks
(Fig. 4a and Supplementary Fig. 7). In addition, we found
that death rate was dose-dependent as mosquitoes treated with
10mgml 1 of AZT succumbed from infection earlier and
with a steadier rate than those treated with 5mgml 1, which
died rapidly starting at 9 days post-infection. These data
suggest that, similar to what was seen in Drosophila, the presence
of vDNA promotes viral persistence in the infected host, and
eventually host survival.
To address the kinetics of vDNA production in vivo, CHIKV-
infected mosquitoes were treated with 10mgml 1 of AZT as
described in the previous section. Untreated mosquitoes
produced and accumulated CHIKV vDNA in a temporal manner,
with roughly 80% of infected mosquitoes presenting vDNA in
their bodies 7 days post-infection (Fig. 4b). However, we observed
a signiﬁcant delay and reduction in the production of vDNA in
AZT-treated mosquitoes, with only 35% of mosquitoes
presenting vDNA in their bodies 7 days post-infection (Fig. 4b).
Interestingly, we also detected the presence of vDNA in legs and
wings, a possible evidence for circulating and disseminating
vDNA, and again found a decrease in the frequency of vDNA in
AZT-treated mosquitoes (Fig. 4c).
We then addressed whether the cause of death was associated
to a loss of resistance or tolerance to the viral infection. Given the
rapid death of infected mosquitoes in the absence of vDNA,
we hypothesized that the mosquitoes were dying from an
overwhelming viral burden or loss of resistance. We quantiﬁed
viral titres at each time point in untreated and AZT-treated
mosquitoes. The untreated mosquitoes displayed typical kinetics
of CHIKV replication, with viral titres peaking in the bodies at
day 3 post-infection, and dissemination and transmission
beginning at day 2 post-infection (Fig. 4d, and Supplementary
Fig. 8, grey dots). Interestingly, in the absence of vDNA we
observed a delay in viral infection (bodies) and dissemination
(legs and wings) at day 2, and in transmission potential (saliva) at
day 5 (Fig. 4d and Supplementary Fig. 8, green dots). One
possibility for these reduced titres could be a reduction in RNA
replication within the bodies of AZT-treated mosquitoes and
thus, a delay in dissemination and transmission. However, we did
not observe signiﬁcant differences in viral RNA by quantitative
PCR with reverse transcription (qRT-PCR) in the bodies (Fig. 4e,
bodies). Interestingly, we detected viral RNA in the legs and
wings of AZT-treated mosquitoes (Fig. 4e; legs and wings) despite
the absence of infectious viral particles (Fig. 4d; legs and wings).
This suggests that while robust viral RNA replication was
occurring in the presence of AZT, infectious particles were
unable to reach the legs, wings and saliva early in infection.
A possible explanation could be the release of viral RNA from the
primary sites of infection as a consequence of cellular/tissue
damage and a loss of tolerance, rather than resistance, to viral
infection in the absence of vDNA.
Given the results from early time points during infection, we
inquired whether viral titres continued to increase late in
infection and speciﬁcally at the time of mosquitoes’ death.
We hypothesized that during this lethal phase of the infection,
viral titres would be steadily increasing. We treated mosquitoes
with 5mgml 1 of AZT, conditions under which the rapid death
of mosquitoes reproducibly occurred 9 days post-infection. Under
these conditions, we again found a reduction in viral transmission
early in infection (day 3 saliva, Supplementary Fig. 8) as well
as a slight reduction in viral titres in the bodies at day 11.
Interestingly, although we did observe an increase in viral titres in
the legs and wings at day nine post-infection, we found no
striking differences during viral infection (bodies), dissemination
(legs and wings) or transmission potential (saliva) at late time
points (Fig. 4d and Supplementary Fig. 8). The results suggest
that death was not due to an increased viral burden (loss of
resistance), but was rather the consequence of a lack of tolerance
for the arbovirus infection. Taken together, these data show that
mosquitoes generate vDNA through an endogenous reverse
transcriptase activity-dependent mechanism. Since the inhibition
of vDNA production leads to the death of the infected mosquitoes
without reducing viral titres, our data suggest that generation of
vDNA in mosquitoes controls tolerance to arbovirus infection,
rather than resistance as observed in Drosophila26.
Discussion
This study provides insight into how mosquitoes become efﬁcient
arbovirus vectors, as they remain infected for their lifetime
without succumbing to infection. We show that fragments of
RNA viruses are reverse transcribed in insect hosts by an
endogenous reverse transcriptase activity and that the resulting
vDNA reinforces the RNAi response against viral infections.
These results further extend our earlier discovery in Drosophila26
to another insect-virus system, suggesting that vDNA biogenesis
could be a widespread phenomenon associated with RNA virus
infections in insects, and linked to virus tolerance in mosquitoes.
This conclusion is not only based on observations with CHIKV in
Ae. albopictus, but also reinforced by the presence of vDNA in
another species, Ae. aegypti, infected with dengue virus. Thus, our
data suggest that vDNA has a crucial role in establishing viral
tolerance, allowing vector survival and, consequently, the spread
of arboviral pathogens18,19.
From a mechanistic perspective, vDNA formation appears to
be an early requirement to mount an effective systemic immunity.
The synthesis of vDNA molecules is dependent on pre-existing
host reverse transcriptase activity, possibly originating from
endogenous retrotransposons, both in infected cultured cells and
mosquitoes. This ensures the rapid appearance of vDNA on
infection, both in cultured cells and in vivo, within 6 h and 2 days,
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12410
6 NATURE COMMUNICATIONS | 7:12410 |DOI: 10.1038/ncomms12410 | www.nature.com/naturecommunications
respectively, when infectious viral particle production is rapidly
increasing. In addition to the presence of vDNA in bodies of
infected mosquitoes, we also detected vDNA in the legs and wings
during infection. Although it is possible that vDNA is formed
in situ when legs and wings are in turn infected, an interesting
possibility would be that vDNA circulates from the original
infected zone and serves as a systemic immune signal to warn or
prime uninfected cells, which impedes infection. We speculate
that mosquitoes rely on active processes such as the assembly and
egress of viral particles, cell lysis or cellular export pathways, to
release vDNA, which could in turn act as a danger signal for
uninfected cells. One can imagine that after the primary infection
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Figure 4 | vDNA is required for mosquito tolerance to CHIKV infection. (a) Survival curve of CHIKV-infected mosquitoes treated daily with 0, 5 or
10mgml 1 of AZT. After the infectious blood meal survival of mosquitoes was monitored daily for 14 days. Continuous lines show the lifespan of
AZT-treated and infected mosquitoes while dotted lines show lifespan of AZT-treated but non-infected (n.i.) mosquitoes. Grey lines: 0mgml 1 AZT;
blue lines: 5mgml 1 AZT and green lines: 10mgml 1 AZT. At least 40 mosquitoes were used for each condition. P-values were calculated using a
Gehan–Breslow–Wilcoxon test using uninfected mosquitoes with the same AZT treatment as a reference. (b,c) Frequency of vDNA in mosquitoes treated
with 10mgml 1 AZT (green, squares) or untreated mosquitoes (grey, circles) in (b) bodies or (c) legs and wings. (d) Individual mosquito viral titres
quantiﬁed by plaque assay. Viral titres were determined in bodies (left panel), legs and wings (middle panel) and saliva (right panel) for untreated
mosquitoes (grey dots) or mosquitoes treated with 10mgml 1 AZT (green dots) at the indicated time points. Standard deviation and geometric mean are
shown. At least 10 mosquitoes were used for each time point. Error bars represent the s.d. A Wilcoxon rank-sum test was used to determine statistical
signiﬁcance (*Po0.05, ****Po0.0001). Absence of P-value represents non-statistical signiﬁcance. (e) Number of viral RNA molecules were calculated by
single mosquito qRT-PCR in bodies (left panel) and legs and wings (right panel) for untreated mosquitoes (grey dots) or mosquitoes treated with
10mgml 1 AZT (green dots) at the indicated time points. Absence of P-value represents non-statistical signiﬁcance. Each experiment was completed at
least three times.
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in the midgut, vDNA is produced and released (along with viral
RNA) into the circulatory system. The vDNA might travel
between tissues to carry antiviral information. While our results
suggest that vDNA is a mobile signal, it is not incompatible
with occasional genomic integration events. Complete and fully
annotated reference genomes for Ae. albopictus28 and other
insects will help solve this puzzle and broaden our observations to
other insect vectors.
Our results show the contribution of vDNA in the production
of virus-speciﬁc small RNAs during the antiviral immune
response. However, we found contrasting results between
cultured cells and living mosquitoes. In the time course of an
infection in cultured cells, vDNA seems mostly to inﬂuence
vpiRNA synthesis. In contrast, vpiRNAs are barely detected
in vivo, and suppressing vDNA formation delays vsiRNA
synthesis, consistent with a more prevalent vsiRNA, rather than
vpiRNA, response in CHIKV-infected mosquitoes. In addition,
the vsiRNAs were produced and detected earlier in infection than
vpiRNAs, consistent with the early requirement for vDNA in
establishing a systemic immune response. When characterizing
vpiRNAs two important observations can be made: (i) at early
time points, we only detected primary vpiRNAs (vpiRNA-like
molecules of the expected size, yet lacking any ping-pong
signature); (ii) in late infection, secondary vpiRNAs (with
ping-pong signature and U1-A10 bias) appeared. These results
suggest that primary piRNAs are possibly generated from viral
RNA replication intermediates, whereas those late in infection
are generated from both viral RNA and vDNA, similar to
endogenous piRNAs. Nonetheless, this may imply a bimodal
innate immune response in mosquitoes, where the early
detection of vsiRNAs may be linked to the initiation of viral
infection and the detection of vpiRNAs late in infection could be
linked to the spread of viral particles to different organs and thus
be a reﬂection of a tissue-speciﬁc RNAi immune response.
Interestingly, a previous study using a West African lineage of
CHIKV detected both vsiRNAs and vpiRNAs in infected Ae.
albopictus mosquitoes at day 4 post-infection6. This difference
could be related not only to the speed by which the virus
reaches different organs, but also to the speciﬁc viral strain
studied. Additional in vivo studies and the establishment of
new insect models infected with their corresponding natural
viruses could help understanding whether the antiviral response
might be targeted towards speciﬁc viruses or tissues using
different RNAi pathways.
Furthermore, these studies open the possibility of additional
role(s) for vDNAs, vsiRNAs and vpiRNAs in the mosquito life
cycle, with impacts on fertility, development, and both
horizontal and vertical transmission of arboviruses. Finally, we
note that the vital role of vDNAs in mosquito tolerance and
arbovirus transmission raises the intriguing possibility that
arboviruses might have evolved mechanisms to counteract vDNA
synthesis or function, analogous to viral suppressors of RNAi in
insect-only viruses29–31.
In conclusion, these studies bring to light the innate immune
mechanisms used by mosquitoes to cope with arbovirus
infections in nature. The rapid synthesis of vDNA molecules is
essential for the synthesis of small RNA molecules and
subsequent tolerance to viral infection, which renders the
mosquito an efﬁcient vector for transmission. In addition, these
studies provide a rationale for a conceptually novel strategy for
vector control. Historically, vector control has relied on the mass
elimination of vectors regardless of their infection status. More
recently, vector population replacement strategies have proposed
to substitute susceptible vectors for insects rendered resistant to
infection by means of genetic modiﬁcation or transfection with
bacterial endosymbionts32. Whereas replacement strategies have
focused until now on increasing resistance to infection, our
results open the way for a new class of replacement strategies that
would act to decrease vector tolerance to infection. Similar to
‘evolution-proof’ insecticides33, selective killing of a small fraction
of the vector population would considerably delay resistance
evolution. Moreover, it is tempting to speculate that lack of
tolerance (loss of function) might be easier to achieve than
resistance (gain of function) to infection. Although much work
remains to be done before such a strategy can be implemented,
evidence of mosquito death following arbovirus infection in the
absence of vDNA provides the proof-of-principle that infected
mosquitoes can be selectively eliminated.
Methods
Cell culture. Aedes albopictus (C6/36 (ATCC CRL-1660) and U4.4 (ref. 34)) and
Aedes aegypti (Aag235) cell lines were a kind gift from G.P. Piljman, Wageningen
University, the Netherlands. Cell lines were maintained at 28 C with 5% CO2 in L-15
Leibovitz medium (Gibco, UK) supplemented with 10% foetal bovine serum (Gibco,
UK), 1% nonessential amino acids (Gibco, UK), 2% tryptose phosphate broth (Sigma)
and 1% penicillin/streptomycin (P/S; Gibco, UK). BHK-21 and Vero cells were
maintained at 37 C with 5% CO2 in Dulbecco’s modiﬁed eagle medium (DMEM)
(Gibco, UK) supplemented with 10% foetal calf serum (Gibco, UK) and 1% P/S.
Viruses. CHIKV from the Indian Ocean Lineage was generated from the
previously described infectious clone36. To generate wild-type CHIKV, 10 mg of
each plasmid was linearized overnight with NotI (Fermentas), puriﬁed by
phenol:chloroform extraction and ethanol precipitation, and resuspended in
nuclease-free H2O. Viral RNAs were in vitro transcribed using the SP6 mMessage
mMachine kit (Ambion, Austin, TX, USA) following the manufacturer’s
instructions. RNAs were treated for 20min with Turbo DNAse, puriﬁed by
phenol:chloroform extraction and ethanol precipitation, and resuspended in
nuclease-free H2O at a concentration of 1 mgml 1 and stored at  80 C. BHK-21
cells (ATCC CCL-10) were then electroporated with 10 mg of the in vitro
transcribed infectious clone RNA. In brief, BHK cells were trypsinized (Gibco, UK),
washed twice with ice-cold phosphate-buffered saline (PBS), and resuspended at a
concentration of 2 107 cells per ml in cold PBS. Cells were then electroporated at
1.2 kV, 25F, with inﬁnite resistance in an XCell Gene Pulser (Bio-Rad, Hercules,
CA). Cells were allowed to recover for 10min at room temperature, added to
pre-warmed media and incubated at 37 C for 48 h. Viral containing supernatants
were recovered, centrifuged at 1,200 r.p.m. for 5min to remove cellular debris, and
viruses were aliquoted and stored at  80 C. Infectious viral titres were
determined by plaque assay on Vero cells as described below.
This study used a dengue virus isolate belonging to serotype 1 (KDH0026A)
derived from a human serum sample collected in 2010 from a clinically ill dengue
patient attending Kamphaeng Phet Provincial Hospital, Thailand37. The isolate was
passaged o5 times in C6/36 cells (ATCC CRL-1660) before experimental
infections of mosquitoes.
Virus titrations. Viral titres were determined by plaque assay on Vero cells
(ATCC CRL-1586). Tenfold serial dilutions of each viral sample were made in
DMEM and incubated on a monolayer of Vero cells for 1 h at 37 C. Following
incubation, cells were overlaid with 0.8% agarose (invitrogen) containing DMEM
supplemented with 2% foetal calf serum and 1% P/S. For all mosquito samples, 1%
antibiotic-antimycotic (Anti-Anti, Gibco, UK) was added. Cells were incubated for
72 h to allow plaques to develop. Cells were then ﬁxed with 4% formalin, agarose
plugs removed and plaques were visualized by the addition of crystal violet
(10% crystal violet and 20% ethanol). Titres were determined on the highest
dilution where plaques could be visualized and counted.
RNA extractions and qRT-PCR. Virus containing samples were extracted with
TRIzol (Invitrogen) following the manufacturer’s instructions and resuspended in
nuclease-free H2O. Before qRT-PCR analysis, all RNA samples were treated for
30min with DNase I (Roche) and the DNase was inactivated by incubation at 75 C
for 30min. qRT-PCR analysis was performed using the RNA-to-Ct kit (Applied
Biosystems, Foster, CA, USA), the forward primer 50-TCACTCCCTGCTGGA
CTTGATAGA-30 and reverse primer 50-TTGACGAACAGAGTTAGGAACAT
ACC-30 , and FAM-labeled probe 50-AGGTACGCGCTTCAAGTTCGGCG-30 as
previously described36. Each sample was run in duplicate and RNA was quantiﬁed
using a puriﬁed in vitro transcribed RNA as a standard.
vDNA PCR analysis. Each sample was homogenized in 50 ml of squishing buffer
(100mM Tris-HCl, 25mM NaCl, 1mM EDTA pH 8, 0.2mgml 1 proteinase K
(eurobio)), incubated at 37 C for 1 h, and Proteinase K was inactivated at 95 C for
2min. 1.5 ml of the treated sample was subjected to PCR. PCR analysis for detection
of vDNA was performed using DreamTaq DNA polymerase (Thermo Scientiﬁc)
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with the CHIKV forward primer 50-CACCGACGTGATGAGAC-30 and reverse
primer 50-GATGCGGCTGCTGTCATGAC-30 , or forward primer 50-TCAC
TCCCTGTTGGACTTGATAGA-30 and reverse primer 50-TTGACGAACAGA
GTTAGGAACATACC-30. For dengue virus forward primer 50-ACCGAGCT
GGGCCAGTGTCA-30 and reverse primer 50-TCCAGCCAGCGGGGTCGTAG-30
were used. The housekeeping 18S rRNA gene was used with the forward primer
50-GGTCGGCGCGGTCGTAGTGTGG-30 and reverse primer 50-TCCTGGT
GGTGCCCTTCCGTCAAT-30 .
RT-PCR for detection of viral RNA was performed using 1 mg of total DNase
treated RNA and SuperScript II reverse transcriptase (Invitrogen) following the
manufacturer’s protocol. 18S rRNA was used as control.
In vitro reverse transcriptase assay. Insect cell extracts: Aag2, C6/36, U4.4 and
S2 (Invitrogen R69007) cell pellets (107 cells per reaction) were washed once with
PBS and ﬂash-frozen in liquid nitrogen. For the reactions, cells were lysed in
CHAPS lysis buffer (10mM Tris-HCl pH 7.5, 400mM NaCl, 1mM MgCl2, 1mM
EGTA, 0.5% CHAPS, 10% glycerol, freshly supplemented with complete
EDTA-free protease inhibitors cocktail (Roche) and 1mM DTT). After incubation
at 4 C for 10min, cell debris were removed by centrifugation at 16,000g for 10min
at 4 C. Supernatants were transferred to clean tubes. Total protein concentration
was determined by Bradford assay (Bio-Rad).
Reverse transcriptase assays were carried out for 15min at 25 C in 50ml
reactions containing 4 mg of insect cell extracts, 320 ng of PAGE-puriﬁed
oligo(dT)20 (Eurogentec), 500 ng of poly(rA) (GE Healthcare) and 1 mCi of
a-32P-dTTP (3,000 Ci mmol 1, PerkinElmer) in 50mM Tris-HCl (pH 7.5),
50mM KCl, 5mM MgCl2 or 0.7mM MnCl2, 5mM DTT and 0.1% Triton X-100.
Then, 5 ml of each reaction were spotted in triplicate onto DE-81 paper; an ion
exchange paper that retains incorporated nucleotides but not free dNTPs. Papers
were washed 5 times with 100ml of 2X saline-sodium citrate solution and exposed
to a PhosphorImager screen. The nucleoside analogue and RT inhibitor AZTTP
was obtained from eEnzyme. Reverse transcriptase assays with AZTTP were
conducted similarly but in 25 ml reactions with twice less amount of each reagent.
Note that we used AZTTP in vitro assays because it corresponds to the bioactive
form of AZT.
In vitro dsRNA silencing assay. 3.5 104 mosquito cells per well (C6/36, U4.4 or
Aag2 cell lines) were seeded in a 96-well plate with different concentrations of AZT
(Sigma), ranging from 0 to 10mM. The day after cell were transfected with 12 ng
pMT ﬁreﬂy luciferase, 6 ng pMT renilla luciferase and 100 ng dsRNA ﬁreﬂy
luciferase, using Effectene (QIAgen) following the manufacturer’s instructions.
Next day cells were washed to remove the excess of plasmids and dsRNA.
Forty-eight hours after transfection, plasmid expression was induced by addition of
CuSO4 to the medium at a ﬁnal concentration of 500 mM for 24 h. Luminiscence
was measured using the Dual-Glo Luciferase Assay System (Promega).
Viral growth curves and RNA synthesis. Virus was diluted to an MOI of 0.1 in
L-15 media without serum and incubated with C6/36, U4.4, and Aag2 cells for 1 h
at 28 C. Cells were washed with PBS to remove unbound virus and complete
media was added. Supernatant was harvested at 24 and 48 h and infectious titres
were determined by plaque assay as described above. Viral RNA was extracted
from the supernatant and quantiﬁed by qRT-PCR. Cells were then harvest and the
vDNA was analysed as described previously.
Mosquito infections and manipulations. A laboratory colony of Ae. albopictus
was used for mosquito infections 8-13 generations after it was collected in 2011 in
Phu Hoa, Ben Cat District, Binh Duong Province, Vietnam. Field-derived Ae.
aegypti mosquitoes originally collected in Nakhon Chum, Muang District,
Kamphaeng Phet Province, Thailand were used for experimental infections within
three generations of laboratory colonization.
Two days before mosquito infection, adult mosquitoes were either left to feed
on 10% sucrose water (untreated) or 10% sucrose water containing either 5 or
10mgml 1 AZT (Sigma, St Louis, MO, USA). On the day of infection, 7-day-old
female mosquitoes were allowed to feed on pre-washed rabbit blood meals
containing 5mM ATP, 106 PFUml 1 CHIKV, and either 10% sucrose or 5 or
10mgml 1 AZT for 30min at 37 C. After blood feeding, engorged females were
sorted into individual boxes (20 mosquitoes/box) and incubated at 28 C with 70%
humidity. Mosquitoes were fed on either 10% sucrose or 10% sucrose containing
AZT (5 or 10mgml 1) for the duration of the experiment. At the end of
incubation, legs and wings were removed, and saliva was collected from individual
mosquitoes by inserting the proboscis into a capillary tube containing 5 ml of foetal
bovine serum for 45min at room temperature. The saliva was collected in 45 ml of
PBS and the body and legs and wings were placed into 2ml round bottom tubes
containing 200ml of PBS and a steel ball (Qiagen, Chatsworth, CA, USA). Bodies,
as well as legs and wings, were ground in a MM300 homogenizer (Qiagen,
Chatsworth, CA, USA) at 30 shakes per s for 2min. Viral titres were determined by
plaque assay and vDNA and RNA levels were analysed as described above. Because
viral titres and RNA levels were strongly non-normally distributed, differences
between AZT treated and untreated individuals were assessed at each time point by
the nonparametric Wilcoxon rank-sum test.
Mosquito survival curves. Mosquito mortality at day 1 was attributed to damage
invoked by feeding/selection procedure, and excluded from further analyses.
Mortality was monitored daily for 14 days, and every day the mosquitoes were fed
with fresh 10% sucrose or AZT in 10% sucrose. In all experiments at least 40
mosquitoes per group were monitored. Each condition was repeated at least two
times. Curves were analysed using Prism6 software (GraphPad Software, La Jolla,
CA, USA).
Small RNA libraries. Total RNA from mosquito cells or from pools of ﬁve whole
untreated or AZT-treated CHIKV-infected mosquitoes was isolated with TRIzol
(invitrogen). 19–33 nts length small RNAs were puriﬁed from a 15% acrylamide/
bisacrylamide (37.5:1), 7M urea gel as described in Gausson et al.38. Puriﬁed RNAs
were used for library preparation using the kit NEBNext Multiplex Small RNA
Library Prep for Illumina (E7300 L) with the 30 adaptor from IDT (linker 1) and
in-house designed indexed primers. Libraries were diluted to 4 nM and sequenced
using NextSeq 500 High Output Kit v2 (75 cycles) on a NextSeq 500 (Illumina, San
Diego, CA, USA). Sequence reads were analysed with in-house Perl scripts.
Bioinformatics analysis of small RNA libraries. The quality of fastq ﬁles
was assessed using graphs generated by ‘FastQC’ (http://www.bioinformatics.bab-
raham.ac.uk/projects/fastqc/). Quality and adaptors were trimmed from each read
using ‘cutadapt’ (https://code.google.com/p/cutadapt/). Only reads with acceptable
quality (phred scoreZ20) were retained. A second set of graphs was generated by
‘FastQC’ (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) on the fastq
ﬁles create by ‘cutadapt’39. Mapping was produced by ‘bowtie1’40 with the ‘-v 1’
(one mismatch between the read and its target). CHIKV reference genome was
from the infectious clone described above36. ‘bowtie1’ generates results in ‘sam’
format. All ‘sam’ ﬁles were analysed by different tools of the package ‘samtools’41 to
produce ‘bam’ indexed ﬁles. To analyse these ‘bam’ ﬁles, different kind of graphs
were generated using home-made R scripts with several Bioconductor libraries as
‘Rsamtools’ or ‘Shortreads’ (http://bioconductor.org/).
Data availability. Sequence data have been deposited in the Sequence Read
Archive with accession code SRP062828. The authors declare that all other data
supporting the ﬁndings of this study are available within the article and its
Supplementary Information Files, or from the corresponding author upon request.
In-house Perl scripts and R scripts are available from the corresponding author
upon request.
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